Molecular imaging in heart failure.
Heart failure (HF), a heterogeneous syndrome of epidemic proportions, is increasingly defined by its underlying molecular and genomic alterations. Molecular cardiac imaging has emerged as a complementary discipline that has improved the understanding of the pathophysiologic principles governing experimental HF and has a potential to revolutionize assessment and management of HF in humans.
Shirani
Jamshid
J
Department of Cardiology, Geisinger Medical Center, 100 North Academy Avenue, Danville, PA 17822-2160, USA. jshirani1@geisinger.edu <jshirani1@geisinger.edu>
Dilsizian
Vasken
V
D019797:3-Iodobenzylguanidine; D000256:Adenoviridae / Q000235:genetics; D017930:Genes, Reporter; D005822:Genetic Vectors; D049452:Green Fluorescent Proteins / Q000378:metabolism; D006333:Heart Failure / Q000503:physiopathology; D006801:Humans; D008156:Luciferases / Q000378:metabolism; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D001616:beta-Galactosidase / Q000378:metabolism
D019275:Radiopharmaceuticals; D049452:Green Fluorescent Proteins; D019797:3-Iodobenzylguanidine; D008156:Luciferases; D001616:beta-Galactosidase